CD14 and Stroke: Monocytes were characterized more in detail by means of flow cytometry (Figures 5I–L) in order to be able to capture the classical activated M1 monocytes (CD14+ CD16+ DR+) and the alternative activated M2 monocytes (CD14++ CD16– DR+) responses, which have been described to have different effects in patients with stroke (12, 13).